The Rwanda Pharmaceutical Students Association (RPSA) will host its annual scientific conference in Kigali on February 7, 2025. The event will bring together emerging leaders in pharmaceutical sciences, biotechnology, and global health to discuss innovative solutions to one of the most pressing challenges of our time – pandemic preparedness.
Bio Usawa is proud to sponsor this important conference as part of our commitment to fostering innovation and equity in global health. The event provides a platform for educating and empowering the next generation of biotech leaders, and we are proud to be a part of this mission.
We are especially excited to announce that our Co-Founder, President, and CEO, Dr. Menghis Bairu, has been invited as a special guest. Dr. Menghis will share his extensive experience and insights on advancing pandemic preparedness through innovation, collaboration, and equitable practices in the biotech sector.
At Bio Usawa, we believe in the transformative power of science to improve lives, and we see this collaboration as a natural extension of our vision.
Bio Usawa has a singular mission: to manufacture high-quality, effective and affordable biosimilars for patients in Africa. We are applying our 100+ years of combined experience in the industry in partnership with governments, agencies, educators and health professionals to make transformative biomedicines in Africa, by Africans, for Africans and beyond.
Click here to learn more about our company's recent successes and download our new White Paper on Regulatory Approaches to Biosimilars in Africa.
At the Africa CEO Forum in Kigali last week, Bio Usawa CEO Dr. Menghis Bairu attended a presidential panel that tackled a question central to Africa’s e…
May 2026At the Rwanda Global Gateway Investment Roadshow this week, our CEO & President Dr. Menghis Bairu joined leaders from government, development finance in…
May 2026Rwanda, in particular, is emerging as one of the few places on the continent where globally trained African scientists, clinicians, and biotech leaders …
May 2026